Clinical Trial Update: Selected Chemotherapy Combined Immunotherapy Treated High Risk Patient After NCRT in Resected Locally Advanced ESCC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update describes using chemotherapy combined with immunotherapy for high-risk patients after neoadjuvant chemoradiation and surgical re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Sichuan Cancer Hospital and Research Institute | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING